This will determine whether treatment is right for you
It means protein, training, dose discipline, and repair support decide whether the deficit looks like fat loss or mixed tissue loss
This decision will consider your individual circumstances, including your medical history, current medications, and lifestyle factors
0.20-0.29%: Confusion, feeling dazed, and disorientation are common
In April 2025, Northstrive Biosciences announced it received preliminary feedback from the FDA on its planned Type B pre-IND meeting, supporting the advancement of its EL-22 program in combination with GLP-1 receptor agonists toward a Phase 2 clinical trial